Phillippa Taberlay
Cited by
Cited by
DNA methylation screening identifies driver epigenetic events of cancer cell survival
DD De Carvalho, S Sharma, JS You, SF Su, PC Taberlay, TK Kelly, ...
Cancer cell 21 (5), 655-667, 2012
Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations
PC Taberlay, J Achinger-Kawecka, ATL Lun, FA Buske, K Sabir, ...
Genome research 26 (6), 719-731, 2016
Polycomb-repressed genes have permissive enhancers that initiate reprogramming
PC Taberlay, TK Kelly, CC Liu, JS You, DD De Carvalho, TB Miranda, ...
Cell 147 (6), 1283-1294, 2011
Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer
PC Taberlay, AL Statham, TK Kelly, SJ Clark, PA Jones
Genome research 24 (9), 1421-1432, 2014
Mining cancer methylomes: prospects and challenges
C Stirzaker, PC Taberlay, AL Statham, SJ Clark
Trends in Genetics 30 (2), 75-84, 2014
OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes
JS You, TK Kelly, DD De Carvalho, PC Taberlay, G Liang, PA Jones
Proceedings of the National Academy of Sciences 108 (35), 14497-14502, 2011
DNA methylation and cancer
PC Taberlay, PA Jones
Epigenetics and Disease, 1-23, 2011
Chromatin remodeler mutations in human cancers: epigenetic implications
KA Skulte, L Phan, SJ Clark, PC Taberlay
Epigenomics 6 (4), 397-414, 2014
Interplay between transcription factors and the epigenome: insight from the role of RUNX1 in leukemia
KH Brettingham-Moore, PC Taberlay, AF Holloway
Frontiers in immunology 6, 2015
The DNA methylation landscape in cancer
K Skvortsova, C Stirzaker, P Taberlay
Essays in biochemistry 63 (6), 797-811, 2019
Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains
A Khoury, J Achinger-Kawecka, SA Bert, GC Smith, HJ French, PL Luu, ...
Nature communications 11 (1), 1-13, 2020
Neurofilament-labeled pyramidal neurons and astrocytes are deficient in DNA methylation marks in Alzheimer's disease
AJ Phipps, JC Vickers, PC Taberlay, A Woodhouse
Neurobiology of aging 45, 30-42, 2016
Targeting epigenetic modifiers in cancer
AF Holloway, PC Oakford
Current medicinal chemistry 14 (24), 2540-2547, 2007
Alterations in three-dimensional organization of the cancer genome and epigenome
J Achinger-Kawecka, PC Taberlay, SJ Clark
Cold Spring Harbor symposia on quantitative biology 81, 41-51, 2016
Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1
PC Oakford, SR James, A Qadi, AC West, SN Ray, AG Bert, PN Cockerill, ...
Leukemia research 34 (9), 1203-1213, 2010
Determinants of a transcriptionally competent environment at the GM-CSF promoter
KH Brettingham-Moore, OR Sprod, X Chen, P Oakford, MF Shannon, ...
Nucleic acids research 36 (8), 2639-2653, 2008
Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups
KA Giles, CM Gould, Q Du, K Skvortsova, JZ Song, MP Maddugoda, ...
Epigenetics & chromatin 12 (1), 1-19, 2019
Distinct mechanisms of regulation of the ITGA6 and ITGB4 genes by RUNX1 in myeloid cells
JL Phillips, PC Taberlay, AM Woodworth, K Hardy, ...
Journal of cellular physiology 233 (4), 3439-3453, 2018
DNA methylation changes following DNA damage in prostate cancer cells
LP Sutton, SA Jeffreys, JL Phillips, PC Taberlay, AF Holloway, M Ambrose, ...
Epigenetics 14 (10), 989-1002, 2019
Genome-wide nucleosome occupancy and DNA methylation profiling of four human cell lines
AL Statham, PC Taberlay, TK Kelly, PA Jones, SJ Clark
Genomics data 3, 94-96, 2015
The system can't perform the operation now. Try again later.
Articles 1–20